Skip to main content
Home / Current Neuropharmacology, Volume 13, Number 5
Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 5, 2015

Graphical Abstracts:
pp. i-v(5)

Favourites:
ADD

Meet Our Editorial Board Member:
pp. 555-555(1)
Author: Baudry, Michel

Favourites:
ADD

Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)
pp. 556-557(2)
Authors: F. Carvalho, Andre; S. McIntyre, Roger

Favourites:
ADD

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
pp. 558-576(19)
Authors: Bortolato, Beatrice; F. Carvalho, Andre; K. Soczynska, Joanna; I. Perini, Giulia; S. McIntyre, Roger

Favourites:
ADD

Treatment-resistant Late-life Depression: Challenges and Perspectives
pp. 577-591(15)
Authors: Knochel, Christian; Alves, Gilberto; Friedrichs, Benedikt; Schneider, Barbara; Schmidt-Rechau, Anna; Wenzler, Sofia; Schneider, Angelina; Prvulovic, David; F. Carvalho, Andre; Oertel-Knochel, Viola

Favourites:
ADD

Pharmacological Approaches for Treatment-resistant Bipolar Disorder
pp. 592-604(13)
Authors: Hui Poon, Shi; Sim, Kang; J. Baldessarini, Ross

Favourites:
ADD

From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings
pp. 605-615(11)
Authors: N. Fountoulakis, Konstantinos; S. McIntyre, Roger; F. Carvalho, Andre

Favourites:
ADD

Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics
pp. 616-635(20)
Authors: de Sousa, Rafael T.; V. Zanetti, Marcus; R. Brunoni, Andre; Machado-Vieira, Rodrigo

Favourites:
ADD

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
pp. 636-655(20)
Authors: D. Rosenblat, Joshua; S. McIntyre, Roger; S. Alves, Gilberto; N. Fountoulakis, Konstantinos; F. Carvalho, Andre

Favourites:
ADD

Future Directions for Pharmacotherapies for Treatment-resistant Bipolar Disorder
pp. 656-662(7)
Authors: Dodd, Seetal; S. Fernandes, Brisa; M. Dean, Olivia

Favourites:
ADD

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
pp. 663-680(18)
Authors: Knochel, Christian; Voss, Martin; Gruter, Florian; S. Alves, Gilberto; Matura, Silke; Sepanski, Beate; Stablein, Michael; Wenzler, Sofia; Prvulovic, David; F. Carvalho, Andre; Oertel-Knochel, Viola

Favourites:
ADD

The Incidence of Akathisia in the Treatment of Schizophrenia with Aripiprazole, Asenapine and Lurasidone: A Meta-Analysis
pp. 681-691(11)
Authors: E. Thomas, Jennifer; Caballero, Joshua; A. Harrington, Catherine

Favourites:
ADD

The Management and Outcomes of Pharmacological Treatments for Tinnitus
pp. 692-700(9)
Authors: Beebe Palumbo, Devon; Joos, Kathleen; De Ridder, Dirk; Vanneste, Sven

Favourites:
ADD

Myalgic Encephalomyelitis: Symptoms and Biomarkers
pp. 701-734(34)
Authors: A. Jason, Leonard; L. Zinn, Marcie; A. Zinn, Mark

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content